BCHE Antibody - N-terminal region
Artikelnummer:
ASB-ARP44208_T100
- Bilder (3)
| Artikelname: | BCHE Antibody - N-terminal region |
| Artikelnummer: | ASB-ARP44208_T100 |
| Hersteller Artikelnummer: | ARP44208_T100 |
| Alternativnummer: | ASB-ARP44208_T100-25UL,ASB-ARP44208_T100-100UL |
| Hersteller: | Aviva |
| Wirt: | Rabbit |
| Kategorie: | Proteine/Peptide |
| Applikation: | IHC, WB |
| Spezies Reaktivität: | Bovine, Canine, Equine, Guinea pig, Human, Mouse, Porcine, Rabbit, Rat, Sheep |
| Immunogen: | The immunogen is a synthetic peptide directed towards the N terminal region of human BCHE |
| Alternative Synonym: | E1, CHE1, CHE2, BCHED |
| Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage. |
|
|
Human Lung |
|
|
WB Suggested Anti-BCHE Antibody Titration: 1.25ug/ml Positive Control: HepG2 cell lysate |
|
|
BCHE antibody - N-terminal region (ARP44208_T100) in Human HepG2 using Western Blot |
Produktgarantie und fachkundiger Support
